NCT00331331View on ClinicalTrials.gov

The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

February 14, 2007

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
UveitisVasculitisOcular Inflammatory Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00331331 - The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease | Biotech Hunter | Biotech Hunter